index - CRCL - PGEB - Plateforme de gestion des échantillons biologiques

Florence Zylbersztejn, Iryna Byelinska, Sandrine Jeanpierre, Léa Barral, Kevin Geistlich, et al.. Human myeloid differentiation by BMP4 signaling through the VDR pathway in acute myeloid leukemia. Cell Death Discovery, 2024, 10, ⟨10.1038/s41420-024-02090-4⟩. ⟨hal-04675664⟩
É. Mathian, Y. Drouet, A. Sexton-Oates, M.G. Papotti, G. Pelosi, et al.. Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project. ESMO Open, 2024, 9 (6), pp.103591. ⟨10.1016/j.esmoop.2024.103591⟩. ⟨hal-04655442⟩
Kévin Berthenet, Eliézer Aïmontché, Sara El Mrini, Johan Brière, Nathalie Pion, et al.. Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment. Scientific Reports, 2024, 14, ⟨10.1038/s41598-024-54140-7⟩. ⟨hal-04482149⟩
Armelle Dufresne, Valéry Attignon, Anthony Ferrari, Laurie Tonon, Sandrine Boyault, et al.. Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. Cancer Medicine, 2024, 13 (7), pp.e7115. ⟨10.1002/cam4.7115⟩. ⟨hal-04646005⟩
Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, et al.. MDR1-expressing CD4⁺T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response. Journal for Immunotherapy of Cancer, 2023, 11 (11), ⟨10.1136/jitc-2023-007733⟩. ⟨hal-04379561⟩
Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, et al.. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor. Cell Death and Differentiation, 2023, 30 (10), pp.2201-2212. ⟨10.1038/s41418-023-01209-x⟩. ⟨hal-04253805⟩

Latest platform publications

Keynumbers